Biobase Lab Instruments Laboratories manufactures the www. biobase. cc reagents distributed by Genprice. The Www. Biobase. Cc reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Biobase lab Instruments. Other Www. products are available in stock. Specificity: Www. Category: Biobase. Group: Cc
CC-115 |
|||
| B6114-10 | ApexBio | 10 mg | EUR 258 |
|
Description: IC50: 21/ 13 nM for mTOR/DNA-PKCC-115 is a inhibitor of mTOR/DNA-PK.The mammalian target of rapamycin (mTOR) kinase is a key mediator of the phosphoinositide 3-kinase /protein kinase B (AKT pathway). |
|||
CC-115 |
|||
| B6114-25 | ApexBio | 25 mg | EUR 508 |
|
Description: IC50: 21/ 13 nM for mTOR/DNA-PKCC-115 is a inhibitor of mTOR/DNA-PK.The mammalian target of rapamycin (mTOR) kinase is a key mediator of the phosphoinositide 3-kinase /protein kinase B (AKT pathway). |
|||
CC-115 |
|||
| B6114-5 | ApexBio | 5 mg | EUR 166 |
|
Description: IC50: 21/ 13 nM for mTOR/DNA-PKCC-115 is a inhibitor of mTOR/DNA-PK.The mammalian target of rapamycin (mTOR) kinase is a key mediator of the phosphoinositide 3-kinase /protein kinase B (AKT pathway). |
|||
CC-115 |
|||
| B6114-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 177 |
|
Description: IC50: 21/ 13 nM for mTOR/DNA-PKCC-115 is a inhibitor of mTOR/DNA-PK.The mammalian target of rapamycin (mTOR) kinase is a key mediator of the phosphoinositide 3-kinase /protein kinase B (AKT pathway). |
|||
CC-223 |
|||
| B6171-10 | ApexBio | 10 mg | EUR 390 |
|
Description: IC50: 16 nMCC-223 is an orally bioavailable mTOR inhibitor.The mammalian target of rapamycin (mTOR) pathway is critical for tumor development, and mTOR inhibitors have revealed modest results. |
|||
CC-223 |
|||
| B6171-25 | ApexBio | 25 mg | EUR 659 |
|
Description: IC50: 16 nMCC-223 is an orally bioavailable mTOR inhibitor.The mammalian target of rapamycin (mTOR) pathway is critical for tumor development, and mTOR inhibitors have revealed modest results. |
|||
CC-223 |
|||
| B6171-5 | ApexBio | 5 mg | EUR 244 |
|
Description: IC50: 16 nMCC-223 is an orally bioavailable mTOR inhibitor.The mammalian target of rapamycin (mTOR) pathway is critical for tumor development, and mTOR inhibitors have revealed modest results. |
|||
CC-930 |
|||
| A3288-10 | ApexBio | 10 mg | EUR 361 |
|
Description: CC-930 is a potent and selective inhibitor of JNK1/JNK2/JNK3 with IC50 values of 61 nM, 7 nM and 6 nM respectively. [1]JNKs (c-Jun N-terminal kinases) belong to kinases which were originally indentified. |
|||
CC-930 |
|||
| A3288-25 | ApexBio | 25 mg | EUR 731 |
|
Description: CC-930 is a potent and selective inhibitor of JNK1/JNK2/JNK3 with IC50 values of 61 nM, 7 nM and 6 nM respectively. [1]JNKs (c-Jun N-terminal kinases) belong to kinases which were originally indentified. |
|||
CC-930 |
|||
| A3288-5 | ApexBio | 5 mg | EUR 225 |
|
Description: CC-930 is a potent and selective inhibitor of JNK1/JNK2/JNK3 with IC50 values of 61 nM, 7 nM and 6 nM respectively. [1]JNKs (c-Jun N-terminal kinases) belong to kinases which were originally indentified. |
|||
CC-401 |
|||
| HY-13022A | MedChemExpress | 50mg | EUR 1153 |
CC-223 |
|||
| HY-16956 | MedChemExpress | 100mg | EUR 1566 |
CC-115 |
|||
| HY-16962 | MedChemExpress | 100mg | EUR 1069 |
CC-885 |
|||
| HY-101488 | MedChemExpress | 5mg | EUR 223 |
CC-671 |
|||
| HY-108709 | MedChemExpress | 1mg | EUR 312 |
CC-90003 |
|||
| HY-112570 | MedChemExpress | 10mg | EUR 326 |
PDGF CC protein |
|||
| 30R-AP043 | Fitzgerald | 20 ug | EUR 273 |
|
Description: Purified recombinant Human PDGF CC protein |
|||